All In Biotech

Drug Trial Radar · NCT00027209

Hormone Replacement in Menopausal Women With Epilepsy

Last checked: Nov 20, 2026Latest source record: May 15, 2006 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 125 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

125

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Sponsor type
NIH
First posted
Nov 29, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Masking
Double
Primary purpose
Treatment
Who can join
Female only, from 0 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate the effect of synthetic hormone replacement therapy on anti-seizure medication levels, menopausal symptom relief, and seizure frequency and safety in menopausal women with epilepsy.

Conditions

  • Menopause
  • Epilepsy

Interventions

  • premproDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New York Presbyterian Hospital-Weill Medical College of Cornell University, Comprehensive Epilepsy Center

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.